Local adherent technique for transplanting mesenchymal stem cells as a potential treatment of cartilage defect
© Koga et al.; licensee BioMed Central Ltd. 2008
Received: 17 March 2008
Accepted: 29 July 2008
Published: 29 July 2008
Current cell therapy for cartilage regeneration requires invasive procedures, periosteal coverage and scaffold use. We have developed a novel transplantation method with synovial mesenchymal stem cells (MSCs) to adhere to the cartilage defect.
For ex vivo analysis in rabbits, the cartilage defect was faced upward, filled with synovial MSC suspension, and held stationary for 2.5 to 15 minutes. The number of attached cells was examined. For in vivo analysis in rabbits, an autologous synovial MSC suspension was placed on the cartilage defect, and the position was maintained for 10 minutes to adhere the cells to the defect. For the control, either the same cell suspension was injected intra-articularly or the defects were left empty. The three groups were compared macroscopically and histologically. For ex vivo analysis in humans, in addition to the similar experiment in rabbits, the expression and effects of neutralizing antibodies for adhesion molecules were examined.
Ex vivo analysis in rabbits demonstrated that the number of attached cells increased in a time-dependent manner, and more than 60% of cells attached within 10 minutes. The in vivo study showed that a large number of transplanted synovial MSCs attached to the defect at 1 day, and the cartilage defect improved at 24 weeks. The histological score was consistently better than the scores of the two control groups (same cell suspension injected intra-articularly or defects left empty) at 4, 12, and 24 weeks. Ex vivo analysis in humans provided similar results to those in rabbits. Intercellular adhesion molecule 1-positive cells increased between 1 minute and 10 minutes, and neutralizing antibodies for intercellular adhesion molecule 1, vascular cell adhesion molecule 1 and activated leukocyte-cell adhesion molecule inhibited the attachment.
Placing MSC suspension on the cartilage defect for 10 minutes resulted in adherence of >60% of synovial MSCs to the defect, and promoted cartilage regeneration. This adherent method makes it possible to adhere MSCs with low invasion, without periosteal coverage, and without a scaffold.
Various methods have been reported for the treatment of articular cartilage injury. Marrow stimulation techniques [1, 2] are the most prevalent, but defects are often filled with fibrous cartilage and the repaired cartilage later degenerates . Autologous osteochondral transplantation  and chondrocyte transplantation  can regenerate hyaline cartilage; however, the invasiveness of the procedures is of concern [6, 7], thereby limiting such applications for the repair of large defects.
Mesenchymal stem cells (MSCs) are an attractive cell source for cartilage regenerative medicine because they can be harvested in a minimally invasive manner, are easily isolated and expanded, and have multipotentiality that includes chondrogenesis [8–10]. In addition, synovial MSCs are especially promising due to their high proliferative capacity and chondrogenic potential [11–16].
Treatment with chondrocytes and MSCs requires the transplantation of a cell and scaffold composite with a periosteum covering, and is presently a common repair method [17, 18]. The method is extremely invasive, however, with a long incision to the skin and capsule to harvest the periosteum, transplantation of the cell/gel composite, and fixation with suturing to the neighboring cartilage. With periosteal coverage, hypertrophy and ossification are of concern . The most popular scaffold is currently composed of collagen gel, which is produced by type I collagen derived from animal skins, thereby introducing the risk of disease transmission and immune reaction .
We developed a novel transplantation procedure with synovial MSCs for cartilage regeneration. The degree of surgical invasion is as minimal as the marrow stimulation techniques, since our procedure can also be performed arthroscopically. Scaffolds are not necessary, thereby increasing the safety and economic feasibility. Our study will advance and extend the clinical application of MSC-based cell therapy for cartilage injury.
Materials and methods
Skeletally mature Japanese White Rabbits weighing approximately 3.2 kg (ranging from 2.8 to 3.6 kg) were used in the experiments. Animal care was in accordance with the guidelines of the animal committee of Tokyo Medical and Dental University. The operation was performed under anesthesia induced by intramuscular injection of 25 mg/kg ketamine hydrochloride and intravenous injection of 45 mg/kg sodium pentobarbital.
Isolation and culture of synovial mesenchymal stem cells in rabbits
Synovium with the subsynovial tissue was harvested from the left knee of the rabbits under anesthesia. The synovium was digested in a 3 mg/ml collagenase D solution (Roche Diagnostics, Mannheim, Germany) in αMEM (Invitrogen Corp., Carlsbad, CA, USA) at 37°C. After 3 hours, digested cells were filtered through a 70-μm nylon filter (Becton Dickinson, Franklin Lakes, NJ, USA), and the remaining tissues were discarded. The digested cells were plated at 5 × 104 cells/cm2 in 150 cm2 culture dishes (Nalge Nunc International, Rochester, NY, USA) in complete culture medium, αMEM containing 10% FBS (lot selected for rapid growth of bone marrow derived MSCs, 100 units/ml penicillin, 100 μg/ml streptomycin, and 250 ng/ml amphotericin B; Invitrogen Corp.), and were incubated at 37°C with 5% humidified CO2. After 3 to 4 days, the medium was changed to remove nonadherent cells, and the adherent cells were cultured for 7 days as passage 0 without refeeding. The cells were then trypsinized, harvested and resuspended to be used for transplantation. We already reported that these cells had characteristics of MSCs [20–22].
The cells that were transplanted in animals to be sacrificed at day 1 were labeled for cell tracking by the fluorescent lipophilic tracer 1,1'-dioctadecyl-3,3,3',3'-tetramethylindocarbocyanine perchlorate (DiI) (Molecular Probes, Eugene, OR, USA). For labeling, the cells were resuspended at 1 × 106 cells/ml in αMEM, and DiI was added at 5 μl/ml in αMEM. After incubation for 20 minutes at 37°C with 5% humidified CO2, the cells were centrifuged at 450 × g for 5 min and washed twice with PBS [20, 23], and the cells were then resuspended in PBS for the transplantation.
Ex vivosequential analysis of the number of attached cells in rabbits
Full-thickness osteochondral defects (5 mm × 5 mm wide, 3 mm deep) were created in the trochlear groove of the femurs of adult rabbits. The distal end of the femurs were then removed, and were precultured in serum-free Dulbecco's MEM (Invitrogen) supplemented with 100 units/ml penicillin (Invitrogen), 100 μg/ml streptomycin (Invitrogen), and 250 ng/ml amphotericin B (Invitrogen) for 24 hours. To determine the length of time needed for cell attachment to the defect, the cartilage defect of the femoral condyle was faced upward. Passage 0 autologous synovial MSCs, precultured for 7 days, were used for the transplantation.
Thirty-six rabbits were used for the in vivo transplantation study. Autologous synovial MSC transplantation was performed 7 days after the harvest. Under anesthesia, the right knee joint was approached through a medial parapatellar incision, and the patella was dislocated laterally. Full-thickness osteochondral defects (5 mm × 5 mm wide, 3 mm deep), whose size were critical for rabbit knees , were created in the trochlear groove of the femur.
The animals were divided into three groups for transplantation. For the control group, the cartilage defect was left empty. For the intra-articular group, 107 DiI-labeled autologous synovial MSCs in 100 μl PBS were injected into the knee joint after the capsule was closed. For the local adherent group, the defect was filled with the cell suspension of 107DiI-labeled autologous synovial MSCs in 100 μl PBS and held stationary for 10 minutes with the defect upward. In no groups were the defects patched, and a periosteum or artificial membrane was not used. All rabbits were returned to their cages after the operation and were allowed to move freely. Animals were sacrificed with an overdose of sodium pentobarbital at 1 day and 4, 12, and 24 weeks after the operation (n = 3 at each time point).
The cartilage defects were examined macroscopically for color, integrity and smoothness. Osteoarthritic changes and synovitis of the knee were also investigated. Macroscopic pictures of the femoral condyles were taken for evaluation using MPS-7 (Sugiura Laboratory Inc., Tokyo, Japan), a dedicated medical photography platform. Digital images were taken using a Nikon Coolpix 4500 digital camera (Nikon, Tokyo, Japan).
Histological examination and fluorescent microscopic examination
The dissected distal femurs were immediately fixed in a 4% paraformaldehyde solution. The specimens were decalcified in 4% ethylenediamine tetraacetic acid solution, dehydrated with a gradient ethanol series, and embedded in paraffin blocks. Sagittal sections 5 μm thick were obtained from the center of each defect and were stained with toluidine blue. Sections dedicated for fluorescent microscopic visualization of DiI-labeled cells were not stained with toluidine blue, and nuclei were counterstained by 4',6-diamidino-2-phenylindole dihydrochloride.
Histological scoring system for cartilage repair
Mostly hyaline cartilage
Normal (compared with host adjacent cartilage)
No metachromatic stain
Moderate (1/2 to 3/4)
Irregular (1/4 to 1/2)
Severely irregular (<1/4)
Thickness of cartilageb
2/3 to 4/3
5/3 to 4/3
1/3 to 2/3 or >5/3
Integration of donor with host adjacent cartilage
Both edges integrated
One edge integrated
Neither edge integrated
Ex vivosequential analysis of the number of attached cells in humans
The study was approved by our Institutional Review Board, and informed consent was obtained from all study subjects. Human synovium and cartilage were harvested during total knee arthroplasty with medial compartment osteoarthritis. Synovial tissue was minced into small pieces, digested in a collagenase solution, and then filtered. Nucleated cells were cultured for 14 days. Passage 3 cells were used for further analyses .
Osteochondral fragments at the lateral femoral condyle were diced with a bone saw. The cartilage defects 2.5 mm in diameter were created and filled with 800 × 103 DiI-labeled human synovial MSCs in 8 μl PBS. After 5, 10, 20, and 30 minutes, the cartilage defects were turned down for 10 minutes. After trypsinization, the DiI-positive cells in the dish were counted, and number of the cell attached to the cartilage defects was calculated by subtracting from 800 × 103 cells.
The sections of the human osteochondral fragments were deparaffinized, washed in PBS, and pretreated with 0.4 mg/ml proteinase K (DAKO, Carpinteria, CA, USA) in Tris–HCl buffer for 15 minutes at room temperature. Endogenous peroxidases were quenched using 3% hydrogen peroxide in methanol for 20 minutes at room temperature. The sections were rinsed three times in PBS for 5 minutes and were briefly blocked with 5% normal horse or rabbit serum (Vector Laboratories, Burlingame, CA, USA) to avoid nonspecific binding of the antibody. The sections were then incubated in mouse monoclonal anti-human intercellular adhesion molecule 1 (ICAM-1) antibody (1:50 dilution; SANBIO BV, Uden, Netherlands) or in goat anti-human vascular adhesion molecule 1 (VCAM-1) antibody (1:100 dilution; R&D Systems, Wiesbarden, Germany) at room temperature for 1 hour. After rinsing in PBS, the tissues were incubated with biotinylated horse anti-mouse or rabbit anti-goat IgG secondary antibody (Vector Laboratories) for 30 minutes at room temperature. After incubation for another 30 minutes with Vectastain ABC reagent (Vector Laboratories), the slides were counterstained with Mayer hematoxylin, dehydrated, and mounted in a xylol-soluble mount (Vitro-Club; Langenbrinck, Emmendingen, Germany).
Neutralizing antibodies for adhesion molecules in human samples
Three million DiI-labeled human synovial MSCs were incubated in 2 ml PBS including 1% BSA with 10 μg/ml neutralizing antibody for human ICAM-1, VCAM-1, activated leukocyte-cell adhesion molecule, or mouse IgG1 isotype control antibody (R&D Systems) for 30 minutes at 37°C with 5% humidified CO2 . After the supernatant was discarded, 800 × 103 cells resuspended in 8 μl PBS were placed on the cartilage defect of osteocartilage fragment and held stationary for 10 minutes. The cartilage defects were then turned down for 10 minutes.
ICAM-1 expression in synovial mesenchymal stem cells after plating on slide grasses
Human synovial MSCs at 500 × 103 in 10 μl PBS were placed on eight-well chamber glass slides (BD Bioscience) and washed by PBS at 1 minute and 10 minutes, and were then fixed with 99.5% acetone for 15 minutes. The glass slides were stained with mouse monoclonal anti-human ICAM-1 antibody (1:10 dilution with PBS in 5% goat serum; R&D Systems) for 2 hours. After rinsing with PBS three times, the slides were stained with goat anti-mouse IgG secondary antibody labeled with Alexa fluor 568 (Invitrogen) for 1 hour. The nuclei were stained with Hoechst 33342 (Invitrogen). The number of ICAM-1-positive cells and nuclei was counted in three high-power fields.
To assess differences, the Kruskal–Wallis test and the Mann–Whitney U test were used. P < 0.05 was considered significant.
Ex vivoanalysis of the number of cells attached to cartilage defects in rabbits
To clarify the minimum time for an adequate number of synovial MSCs to attach to the cartilage defect by the local adherent technique, we performed an ex vivo sequential analysis using rabbit synovial MSCs and rabbit cartilage (Figure 1a). The number of attached cells increased in a time-dependent manner, and more than 60% of the cells attached in 10 minutes (Figure 1b).
Macroscopic observation for the in vivostudy
Osteochondral defects were created in rabbit knees. For the control group, the cartilage defect was left empty. For the intra-articular group, synovial MSCs were injected into the knee joint after the capsule was closed. For the local adherent group, the defect was filled with the synovial MSC suspension and faced upward for 10 minutes according to the ex vivo analyses.
At 1 day, the cartilage defects were overlaid with blood clots, and there seemed to be no obvious differences among the control, intra-articular, and local adherent groups macroscopically (data not shown).
At 12 weeks, in the control and intra-articular groups, the reddish regions decreased in size but still remained locally (Figure 2b, images d and e). In the local adherent group, the border between repaired tissue and neighboring cartilage appeared less distinct (Figure 2b, image f).
At 24 weeks, the cartilage defect area in the control group decreased but still remained (Figure 2b, image g). In the intra-articular group, the defects were covered with whitish tissue but the margins were still distinct (Figure 2b, image h). In the local adherent group, the peripheral lesion of the defect appeared to integrate into the surrounding native cartilage (Figure 2b, image i).
In all three groups there were no obvious features of hydrarthrosis or synovial proliferation. Mild spur formation was observed on the edge of the trochlear groove of the femur in some samples of the control group, but there were no osteoarthritic changes of the femorotibial joint in any groups.
Histological observation for in vivostudy
At 4 weeks, the defect in the control group was filled with fibrous tissue and the cartilage matrix formation was poor (Figure 3b, image a). In the intra-articular group, although more cartilage matrix could be observed than in the control group, the height of the repaired tissue was lower than that of the surrounding cartilage (Figure 3b, image b). In the local adherent group, the defect was filled with abundant cartilage matrix. In addition in the local adherent group, remodeling of the cartilage into the underlying bone was observed in deep areas (Figure 3b, image c).
At 12 weeks, in the control and intra-articular groups, the defects were filled with fibrous tissues and were poorly healed (Figure 3b, images d and e). In the local adherent group, the cartilage matrix at the defect still remained, and the border between regenerated cartilage and subchondral bone moved upward. Integration between native cartilage and regenerated tissue appeared to be improved (Figure 3b, image f).
At 24 weeks, in the control and intra-articular groups, the cartilage defects were still not healed (Figure 3b, images g and h). In the local adherent group, the regenerated cartilage matrix was well developed. The subchondral bone moved further upward, and the thickness of the regenerated cartilage was similar to that of the neighboring cartilage. The borders between the native and regenerated tissue were well integrated (Figure 3b, image i).
The histological scores of the local adherent group improved continuously through 24 weeks and were always better than those of the control group and the intra-articular group at each point (Figure 3c).
Ex vivoanalysis of human synovial mesenchymal stem cell attachment to human cartilage defect
The results described above were obtained using rabbit MSCs. We investigated whether human MSC exhibited the same capacity as rabbit cells to adhere to cartilage with the same kinetics. The defects of cartilage obtained from humans were faced upward, filled with 800 × 103 DiI-labeled human synovial MSCs, and the position maintained for 5 to 30 minutes.
Morphological event during a 10 minute period
We finally examined the morphological change of human synovial MSCs during a 10-minute period after plating on a culture dish. Most cells looked thick and round at 1 minute. They became thinner, larger, and polygonal at 10 minutes (Figure 5c).
For successful cartilage regeneration with MSCs, a sufficient number of cells are required in the defect of the cartilage. The number of MSCs decreased along with the period during chondrogenesis in vitro [12, 27] and in vivo  due to apoptosis of the MSCs . Chondrogenic potential of MSCs depends on the cell number in vitro . We previously reported that transplantation of synovial MSCs/gel composites with 5 × 107 cells/ml provided better results than transplantation of composites with 106 cells/ml for the similar cartilage defects in rabbits . These findings indicate that transplanted MSCs do not increase, and a higher number of MSCs can provide better results for cartilage regeneration. In the present study we chose a dose of 108 cells/ml MSC suspension for the ex vivo and in vivo investigation. This concentration is the maximum for preparing cell suspension.
We previously created the same full-thickness cartilage defect in rabbits, and transplanted a synovial MSC/collagen gel complex, which was covered with periosteum. The defect was repaired successfully , and histological scores were similar using collagen gel and using the local adherence technique.
We believe that the local adherent technique is much less invasive and more attractive for clinical application.
Before we performed this research, we had speculated that intra-articular injection of MSCs might result in better improvement of the cartilage defect than it actually did. Practically, most of the intra-articular injected cells adhered to synovial tissue (data not shown), and only a small portion of the cells adhered to the cartilage defect. Injection of more cells would increase the number of cells that adhered to the defect; however, the injection of a large number of cells would also increase the number of cells that adhered to the synovium, thereby increasing the risk of adverse effects such as synovial proliferation. The local adherent technique we describe here made it possible to adhere the cells to the defect site more effectively than an intra-articular injection technique.
In this research, human synovial MSCs attached to the cartilage defect 10 minutes after plating already expressed ICAM-1 and VCAM-1, and neutralizing antibodies for ICAM-1, VCAM-1, or activated leukocyte-cell adhesion molecule inhibited the attachment. The ICAM-1-positive cell rate also increased 10 minutes after plating on glass slides. Attachment of synovial MSCs within 10 minutes was mediated by these adhesion molecules. Their modification may have increased the efficacy of cell attachment.
Our ex vivo studies demonstrated that more than 60% of synovial MSCs adhered to the cartilage defect after synovial MSC suspension was placed on the cartilage defect for 10 minutes both in humans and rabbits. The remaining nonadherent synovial MSCs seemed to attach to synovial tissue in the knee joint. When we injected 107 GFP-positive rat synovial MSCs into the knee with meniscal defect in rats, GFP-positive cells were observed in the meniscal defect and in the synovial tissues. GFP mRNA expressions were also detected in the synovium, but not in the brain, the lung, the liver, the kidney, and the spleen . Furthermore, our in vivo imaging system could not be detected in any other organs expect the knee when luciferase-positive synovial MSCs were injected into normal rat knee (data not shown). These findings indicate that synovial MSCs transplanted into the knee are not distributed to other organs.
We previously compared the in vivo chondrogenic potential of synovial MSCs, bone marrow MSCs, adipose MSCs, and muscle MSCs by transplanting them into cartilage defects in rabbits. Synovial MSCs and bone marrow MSCs had much more chondrogenic potential than adipose MSCs and muscle MSCs . For clinical safety, autologous human serum should be used instead of FBS. We recently reported that autologous human serum predominated in increasing the proliferation of human synovial MSCs rather than human bone marrow MSCs . These results indicate that synovial MSCs and bone marrow MSCs are useful cell sources for cartilage regeneration, but it is easier to prepare a sufficient number in synovial MSCs than in bone marrow MSCs when autologous serum is used.
In the original autologous chondrocyte transplantation technique, the cartilage defect was covered with the periosteum and then chondrocyte suspension was injected into the defect . One poor aspect of the autologous chondrocyte transplantation method was the leakage of the cell suspension; however, the original autologous chondrocyte transplantation method produced successful results. We speculate that chondrocytes in suspension might adhere to the cartilage defect soon after chondrocyte suspension is injected into the defect.
We developed a novel implantation procedure with synovial MSCs for cartilage regeneration. The local adherent technique could achieve successful cartilage regeneration with low invasion, without periosteal coverage, and without a scaffold. This will advance and extend clinical application of MSC-based cell therapy for cartilage injury.
= bovine serum albumin
- DiI = 1:
= fetal bovine serum
= green fluorescent protein
= intercellular adhesion molecule 1
modified Eagle's medium
= mesenchymal stem cell
= phosphate-buffered saline
= vascular cell adhesion molecule 1.
The authors thank Kenichi Shinomiya, MD, PhD, for continuous support, Miyoko Ojima for expert help with histology, and Alexandra Peister, PhD, for proofreading.
The present study was supported by grants from the Japanese Ministry of Education Global Center of Excellence Program, International Research Center for Molecular Science in Tooth and Bone Diseases to TMu and from the Japan Society for the Promotion of Science (16591478) to IS.
- Johnson LL: Arthroscopic abrasion arthroplasty historical and pathologic perspective: present status. Arthroscopy. 1986, 2: 54-69.View ArticlePubMedGoogle Scholar
- Minas T, Nehrer S: Current concepts in the treatment of articular cartilage defects. Orthopedics. 1997, 20: 525-538.PubMedGoogle Scholar
- Gilbert JE: Current treatment options for the restoration of articular cartilage. Am J Knee Surg. 1998, 11: 42-46.PubMedGoogle Scholar
- Matsusue Y, Yamamuro T, Hama H: Arthroscopic multiple osteochondral transplantation to the chondral defect in the knee associated with anterior cruciate ligament disruption. Arthroscopy. 1993, 9: 318-321.View ArticlePubMedGoogle Scholar
- Brittberg M, Lindahl A, Nilsson A, Ohlsson C, Isaksson O, Peterson L: Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med. 1994, 331: 889-895. 10.1056/NEJM199410063311401.View ArticlePubMedGoogle Scholar
- Reddy S, Pedowitz DI, Parekh SG, Sennett BJ, Okereke E: The morbidity associated with osteochondral harvest from asymptomatic knees for the treatment of osteochondral lesions of the talus. Am J Sports Med. 2007, 35: 80-85. 10.1177/0363546506290986.View ArticlePubMedGoogle Scholar
- Whittaker JP, Smith G, Makwana N, Roberts S, Harrison PE, Laing P, Richardson JB: Early results of autologous chondrocyte implantation in the talus. J Bone Joint Surg Br. 2005, 87: 179-183. 10.1302/0301-620X.87B2.15376.View ArticlePubMedGoogle Scholar
- Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR: Multilineage potential of adult human mesenchymal stem cells. Science. 1999, 284: 143-147. 10.1126/science.284.5411.143.View ArticlePubMedGoogle Scholar
- Prockop DJ: Marrow stromal cells as stem cells for nonhematopoietic tissues. Science. 1997, 276: 71-74. 10.1126/science.276.5309.71.View ArticlePubMedGoogle Scholar
- Sekiya I, Larson BL, Smith JR, Pochampally R, Cui JG, Prockop DJ: Expansion of human adult stem cells from bone marrow stroma: conditions that maximize the yields of early progenitors and evaluate their quality. Stem Cells. 2002, 20: 530-541. 10.1634/stemcells.20-6-530.View ArticlePubMedGoogle Scholar
- Sakaguchi Y, Sekiya I, Yagishita K, Muneta T: Comparison of human stem cells derived from various mesenchymal tissues: superiority of synovium as a cell source. Arthritis Rheum. 2005, 52: 2521-2529. 10.1002/art.21212.View ArticlePubMedGoogle Scholar
- Shirasawa S, Sekiya I, Sakaguchi Y, Yagishita K, Ichinose S, Muneta T: In vitro chondrogenesis of human synovium-derived mesenchymal stem cells: optimal condition and comparison with bone marrow-derived cells. J Cell Biochem. 2006, 97: 84-97. 10.1002/jcb.20546.View ArticlePubMedGoogle Scholar
- Mochizuki T, Muneta T, Sakaguchi Y, Nimura A, Yokoyama A, Koga H, Sekiya I: Higher chondrogenic potential of fibrous synovium- and adipose synovium-derived cells compared with subcutaneous fat-derived cells: distinguishing properties of mesenchymal stem cells in humans. Arthritis Rheum. 2006, 54: 843-853. 10.1002/art.21651.View ArticlePubMedGoogle Scholar
- Yoshimura H, Muneta T, Nimura A, Yokoyama A, Koga H, Sekiya I: Comparison of rat mesenchymal stem cells derived from bone marrow, synovium, periosteum, adipose tissue, and muscle. Cell Tissue Res. 2007, 327: 449-462. 10.1007/s00441-006-0308-z.View ArticlePubMedGoogle Scholar
- Nagase T, Muneta T, Ju YJ, Hara K, Morito T, Koga H, Nimura A, Mochizuki T, Sekiya I: Analysis of the chondrogenic potential of human synovial stem cells according to harvest site and culture parameters in knees with medial compartment osteoarthritis. Arthritis Rheum. 2008, 58: 1389-1398. 10.1002/art.23418.View ArticlePubMedGoogle Scholar
- Nimura A, Muneta T, Koga H, Mochizuki T, Suzuki K, Makino H, Umezawa A, Sekiya I: Increased proliferation of human synovial mesenchymal stem cells with autologous human serum: comparisons with bone marrow mesenchymal stem cells and with fetal bovine serum. Arthritis Rheum. 2008, 58: 501-510. 10.1002/art.23219.View ArticlePubMedGoogle Scholar
- Ochi M, Uchio Y, Kawasaki K, Wakitani S, Iwasa J: Transplantation of cartilage-like tissue made by tissue engineering in the treatment of cartilage defects of the knee. J Bone Joint Surg Br. 2002, 84: 571-578. 10.1302/0301-620X.84B4.11947.View ArticlePubMedGoogle Scholar
- Wakitani S, Imoto K, Yamamoto T, Saito M, Murata N, Yoneda M: Human autologous culture expanded bone marrow mesenchymal cell transplantation for repair of cartilage defects in osteoarthritic knees. Osteoarthr Cartil. 2002, 10: 199-206. 10.1053/joca.2001.0504.View ArticlePubMedGoogle Scholar
- Charriere G, Bejot M, Schnitzler L, Ville G, Hartmann DJ: Reactions to a bovine collagen implant. Clinical and immunologic study in 705 patients. J Am Acad Dermatol. 1989, 21: 1203-1208.View ArticlePubMedGoogle Scholar
- Koga H, Muneta T, Ju YJ, Nagase T, Nimura A, Mochizuki T, Ichinose S, Mark von der K, Sekiya I: Synovial stem cells are regionally specified according to local microenvironments after implantation for cartilage regeneration. Stem Cells. 2007, 25: 689-696. 10.1634/stemcells.2006-0281.View ArticlePubMedGoogle Scholar
- Koga H, Muneta T, Nagase T, Nimura A, Ju YJ, Mochizuki T, Sekiya I: Comparison of mesenchymal tissues-derived stem cells for in vivo chondrogenesis: suitable conditions for cell therapy of cartilage defects in rabbit. Cell Tissue Res. 2008, 333: 207-215. 10.1007/s00441-008-0633-5.View ArticlePubMedGoogle Scholar
- Ju YJ, Muneta T, Yoshimura H, Koga H, Sekiya I: Synovial mesenchymal stem cells accelerate early remodeling of tendon-bone healing. Cell Tissue Res. 2008, 332: 469-478. 10.1007/s00441-008-0610-z.View ArticlePubMedGoogle Scholar
- Mothe AJ, Tator CH: Proliferation, migration, and differentiation of endogenous ependymal region stem/progenitor cells following minimal spinal cord injury in the adult rat. Neuroscience. 2005, 131: 177-187. 10.1016/j.neuroscience.2004.10.011.View ArticlePubMedGoogle Scholar
- Otsuka Y, Mizuta H, Takagi K, Iyama K, Yoshitake Y, Nishikawa K, Suzuki F, Hiraki Y: Requirement of fibroblast growth factor signaling for regeneration of epiphyseal morphology in rabbit full-thickness defects of articular cartilage. Dev Growth Differ. 1997, 39: 143-156. 10.1046/j.1440-169X.1997.t01-1-00003.x.View ArticlePubMedGoogle Scholar
- Wakitani S, Goto T, Pineda SJ, Young RG, Mansour JM, Caplan AI, Goldberg VM: Mesenchymal cell-based repair of large, full-thickness defects of articular cartilage. J Bone Joint Surg Am. 1994, 76: 579-592.PubMedGoogle Scholar
- Ruster B, Gottig S, Ludwig RJ, Bistrian R, Muller S, Seifried E, Gille J, Henschler R: Mesenchymal stem cells display coordinated rolling and adhesion behavior on endothelial cells. Blood. 2006, 108: 3938-3944. 10.1182/blood-2006-05-025098.View ArticlePubMedGoogle Scholar
- Sekiya I, Vuoristo JT, Larson BL, Prockop DJ: In vitro cartilage formation by human adult stem cells from bone marrow stroma defines the sequence of cellular and molecular events during chondrogenesis. Proc Natl Acad Sci USA. 2002, 99: 4397-4402. 10.1073/pnas.052716199.PubMed CentralView ArticlePubMedGoogle Scholar
- Ichinose S, Tagami M, Muneta T, Sekiya I: Morphological examination during in vitro cartilage formation by human mesenchymal stem cells. Cell Tissue Res. 2005, 322: 217-226. 10.1007/s00441-005-1140-6.View ArticlePubMedGoogle Scholar
- Yokoyama A, Sekiya I, Miyazaki K, Ichinose S, Hata Y, Muneta T: In vitro cartilage formation of composites of synovium-derived mesenchymal stem cells with collagen gel. Cell Tissue Res. 2005, 322: 289-298. 10.1007/s00441-005-0010-6.View ArticlePubMedGoogle Scholar
- Mizuno K, Muneta T, Morito T, Ichinose S, Koga H, Nimura A, Mochizuki T, Sekiya I: Exogenous synovial stem cells adhere to defect of meniscus and differentiate into cartilage cells. J Med Dent Sci. 2008, 55: 101-111.PubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.